4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-155965
Options or other derivatives
- Chief Legal Officer acquired 97,066 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ali-Jackson Kamil Chief Legal Officer | 2016-12-15 | Grant or award · Stock option (right to buy) | +83,200 | 83,200 | D: show line 1 in the form | ||
| Ali-Jackson Kamil Chief Legal Officer | 2016-12-15 | Grant or award · Restricted stock units | +13,866 | 13,866 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…